Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GABARRE, Jean")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 23 of 23

  • Page / 1
Export

Selection :

  • and

HAART et modification de l'épidémiologie, du traitement et du pronostic des patients séropositifs pour le VIH atteints de maladie de Kaposi et de lymphome : Cancer et VIH = HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphomaGABARRE, Jean; BOSSI, Philippe.Bulletin du cancer. 2003, Vol 90, Num 5, pp 419-425, issn 0007-4551, 7 p.Article

In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSV infection while both v-FLIP and v-GPCR become involved during the lytic cycleLACOSTE, Vincent; NICOT, Christophe; GESSAIN, Antoine et al.British journal of haematology. 2007, Vol 138, Num 4, pp 487-501, issn 0007-1048, 15 p.Article

High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV diseaseGABARRE, Jean; MARCELIN, Anne-Geneviève; SPINA, Michele et al.Haematologica (Roma). 2004, Vol 89, Num 9, pp 1100-1108, issn 0390-6078, 9 p.Article

Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphomaBOUE, Francois; GABARRE, Jean; GISSELBRECHT, Christian et al.Journal of clinical oncology. 2006, Vol 24, Num 25, pp 4123-4128, issn 0732-183X, 6 p.Article

Prognostic factors and outcome of human herpesvirus 8 -associated primary effusion lymphoma in patients with AIDSBOULANGER, Emmanuelle; GERARD, Laurence; GABARRE, Jean et al.Journal of clinical oncology. 2005, Vol 23, Num 19, pp 4372-4380, issn 0732-183X, 9 p.Article

AIDS-related non-Hodgkin lymphoma : final analysis of 485 patients treated with risk-adapted intensive chemotherapy. CommentarySTRAUS, David J; MOUNIER, Nicolas; CHICHINO, Guido et al.Blood. 2006, Vol 107, Num 10, issn 0006-4971, 3819-3820,3832-3840 [11 p.]Article

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infectionSPINA, Michele; GABARRE, Jean; VACCHER, Emanuela et al.Blood. 2002, Vol 100, Num 6, pp 1984-1988, issn 0006-4971, 5 p.Article

Human immunodeficiency virus-related lymphoma: Relation between clinical features and histologic subtypesGABARRE, Jean; RAPHAEL, Martine; SCHLAIFER, Daniel et al.The American journal of medicine. 2001, Vol 111, Num 9, pp 704-711, issn 0002-9343Article

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trialMORSCHHAUSER, Franck; FITOUSSI, Olivier; JU LI et al.European journal of cancer (1990). 2013, Vol 49, Num 13, pp 2869-2876, issn 0959-8049, 8 p.Article

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELAFITOUSSI, Olivier; BELHADJ, Karim; HERBRECHT, Raoul et al.Haematologica (Roma). 2011, Vol 96, Num 8, pp 1136-1143, issn 0390-6078, 8 p.Article

Genomic imbalances in AIDS-related lymphomas : relation with tumoral Epstein-Barr virus statusVAGHEFI, Parissa; MARTIN, Antoine; PREVOT, Sophie et al.AIDS (London). 2006, Vol 20, Num 18, pp 2285-2291, issn 0269-9370, 7 p.Article

Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cellsBOULANGER, Emmanuelle; DUPREZ, Renan; DELABESSE, Eric et al.International journal of cancer. 2005, Vol 115, Num 4, pp 511-518, issn 0020-7136, 8 p.Article

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapyBESSON, Caroline; GOUBAR, Aicha; HUERRE, Michel et al.Blood. 2001, Vol 98, Num 8, pp 2339-2344, issn 0006-4971Article

Characteristics of B-Cell Lymphomas in HIV/HCV-Coinfected Patients During the Combined Antiretroviral Therapy Era: An ANRS CO16 LYMPHOVIR Cohort StudyTERRIER, Benjamin; COSTAGLIOLA, Dominique; LETRANCHANT, Lorraine et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 2, pp 249-253, issn 1525-4135, 5 p.Article

Impact of the use of autologous stem cell transplantation at first relapse both in naïve and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 studyLE GOUILL, Steven; DE GUIBERT, Sophie; FRUCHART, Christophe et al.Haematologica (Roma). 2011, Vol 96, Num 8, pp 1128-1135, issn 0390-6078, 8 p.Article

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trialRECHER, Christian; COIFFIER, Bertrand; GHESQUIERES, Herve et al.Lancet (British edition). 2011, Vol 378, Num 9806, pp 1858-1867, issn 0140-6736, 10 p.Article

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosisRIBRAG, Vincent; KOSCIELNY, Serge; CASASNOVAS, Olivier et al.Blood. 2009, Vol 113, Num 14, pp 3307-3313, issn 0006-4971, 7 p.Article

Traitement des lymphomes malins non hodgkiniens : Répercussions économiques de l'utilisation du rituximab (Mabthera®) versus chimiothérapies conventionnelles = Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Maibthera®) versus conventional chemotherapyMALLITI, Miriam; JUNOT, Helga; FIEVET, Marie-Hélène et al.Annales de médecine interne (Paris). 2003, Vol 154, Num 3, pp 139-147, issn 0003-410X, 9 p.Article

Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte TrialsSIBON, David; FOURNIER, Marion; SONET, Anne et al.Journal of clinical oncology. 2012, Vol 30, Num 32, pp 3939-3946, issn 0732-183X, 8 p.Article

Positron Emission Tomography-Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial ParticipantsTROTMAN, Judith; FOURNIER, Marion; FORSYTH, Cecily et al.Journal of clinical oncology. 2011, Vol 29, Num 23, pp 3194-3200, issn 0732-183X, 7 p.Article

Chemotherapy plus involved-field radiation in early-stage Hodgkin's diseaseFERME, Christophe; EGHBALI, Houchingue; LEDERLIN, Pierre et al.The New England journal of medicine. 2007, Vol 357, Num 19, pp 1916-1927, issn 0028-4793, 12 p.Article

Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma : A study from the groupe d'etude des lymphomes de l'adulteCASASNOVAS, Rend-Olivier; MOUNIER, Nicolas; BIENVENU, Jacques et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1732-1740, issn 0732-183X, 9 p.Article

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphomaGISSELBRECHT, Christian; LEPAGE, Eric; HERMINE, Olivier et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2472-2479, issn 0732-183XArticle

  • Page / 1